Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arrowhead Pharma (NQ: ARWR )

84.13 USD +2.06 (+2.51%)
Official Closing Price Updated: 7:29 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Arrowhead Pharma

< Previous 1 2
...
21 22 23 24 25 26 27 28 Next >
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Arrowhead Pharmaceuticals, Inc. (ARWR)
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company")... 
From PR Newswire
20 Biggest Mid-Day Losers For Wednesday
AgroFresh Solutions Inc (NASDAQ: AGFS) shares declined 39.7 percent to $2.83. AgroFresh posted Q3 earnings of $0.15 ... 
Tags Markets AGFS Mid/Day Losers
From Benzinga
A Couple Of News Dumps You May Have Missed On Tuesday Night
The entire nation was glued to their TV sets or smartphones for the latest U.S. election updates. This also proved to be a convenient ... 
Tags News News Dump GPRO
From Benzinga
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Arrowhead Pharmaceuticals, I
Levi & Korsinsky announces it has commenced an investigation of Arrowhead Pharmaceuticals, Inc. concerning possible violations of federal securities laws by certain officers and directors 
From Business Wire News Releases
Arrowhead Research Declining With Trend-Confirming Volume (ARWR)
Shares of Arrowhead Research are trading down 24.5% to $4.61 today on above average volume. Today's volume of 2.2 million shares tops the average 30-day volume of 667,000 shares.... 
From Comtex SmarTrend® News Briefs
25 Stocks Moving In Wednesday's Pre-Market Session
Gainers Corrections Corp Of America (NYSE: CXW) shares rose 16.3 percent to $16.50 in pre-market trading following Donald ... 
Tags BTG Benzinga OMER
From Benzinga
BRIEF-Arrowhead Pharmaceuticals provides update on Heparc-2004
* Notified verbally by United States FDA of its decision to place a clinical hold on heparc-2004 
Tags companyNews
From Reuters: Company News
Arrowhead Pharmaceuticals Provides Update on Heparc-2004 Study
Arrowhead provides an update on its Heparc-2004 clinical study of ARC-520, its therapeutic candidate under clinical investigation for the treatment of chronic hepatitis B virus (HBV) infection. 
From Business Wire News Releases
Arrowhead Pharmaceuticals to Present at Upcoming Conferences
Arrowhead Pharmaceuticals will present at multiple conferences in November 2016 
From Business Wire News Releases
BRIEF-Arrowhead Pharmaceuticals files for mixed shelf of up to $200 mln - SEC filing
* Files for mixed shelf of up to $200 million - SEC filing Source text: (http://bit.ly/2e5NfCw) Further company coverage: 
Tags companyNews
From Reuters: Company News
Relative Strength Alert For Arrowhead Pharmaceuticals
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
15 Stocks Which Plummeted Three Days On Increasing Volume
The following stocks posted three-day sell offs on increasing volume spanning the trading days from October 24 to October ... 
Tags NLNK SCOR Increasing Volume
From Benzinga
Arrowhead Pharmaceuticals to Present Data on ARC-AAT at The Liver Meeting®
Arrowhead Pharmaceuticals will present data on ARC-AAT at the AASLD Liver Meeting in Boston in November 2016 
From Business Wire News Releases
Biotech Stocks on Investors' Radar -- BioMarin Pharma, Keryx Biopharma, Puma Biotech, and Arrowhead Pharma
From PR Newswire
Analysts Predict 39% Upside For XBI
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
What's Next for Alnylam Pharmaceuticals, Inc. After Its Phase 3 Failure?
Tags MDCO ALNY ARWR
From Motley Fool
Alnylam’s discontinued late-stage drug put a buzzed-about drug technology in its crosshairs
And Wall Street is scattered all over the place. 
Tags Health/Care ABUS Medical Products
From MarketWatch
Alnylam Halts Drug Testing After 18 Deaths; Value Seen In Cousin Drug
Alnylam stock tanked Thursday after the drugmaker ended testing on an amyloidosis drug after several patients died. 
Tags Technology
From Investor's Business Daily
18 Stocks Moving In Thursday's Pre-Market Session
Gainers PhotoMedex Inc (NASDAQ: PHMD) rose 52.2 percent to $1.75 in pre-market trading after ICTV Brands, Inc agreed to ... 
Tags ARWR TWTR AUPH
From Benzinga
BRIEF-Arrowhead and Spring Bank report clinical collaboration
* Arrowhead And Spring Bank Announce Clinical Collaboration For Arc-520 and SB 9200 in chronic hepatitis B 
Tags companyNews
From Reuters: Company News
Arrowhead and Spring Bank Announce Clinical Collaboration for ARC-520 and SB 9200 in Chronic Hepatitis B
Arrowhead and Spring Bank announce collaboration to study ARC-520 and SB 9200 in chronic hepatitis B 
From Business Wire News Releases
Biotechs with Key Corporate Developments
From PR Newswire
Arrowhead Pharmaceuticals (ARWR) Keeps Upward Progress Rolling
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) rose 1.4% to $7.40 after gaining 3.7% on Thursday. Share volume was one million, compared to an all-day average of 790,000 
From Baystreet.ca RSS Feed
16 Stocks Moving In Friday's Pre-Market Session
Gainers Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) rose 13.6 percent to $3.00 in pre-market trading as the company ... 
Tags CATB CAMP Benzinga
From Benzinga
15 Biggest Mid-Day Gainers For Thursday
Catabasis Pharmaceuticals Inc (NASDAQ: CATB) shares jumped 59 percent to $7.13. Catabasis Pharmaceuticals and Sarepta ... 
Tags HIMX REXX EBAY
From Benzinga
Arrowhead's Landmark Deal With Amgen Sends Shares Shooting Higher
Shares of Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) climbed as much as 15 percent to $8.09 after it announced a joint collaboration ... 
Tags ALNY Analyst Color Price Target
From Benzinga
3 Top Stocks Under $10
Tags ARWR TLGT INFN
From Motley Fool
Why Arrowhead Pharmaceuticals Stock Spiked Today
Tags ARWR AMGN
From Motley Fool
Mid-Morning Market Update: Markets Edge Lower; PepsiCo Beats Q3 Expectations
Following the market opening Thursday, the Dow traded down 0.06 percent to 18,329.07 while the NASDAQ declined 0.16 ... 
Tags YZC Earnings ARWR
From Benzinga
UPDATE 1-Amgen, Arrowhead team up on gene-therapies for heart disease
Sept 29 (Reuters) - Amgen Inc said on Thursday it would buy a stake in Arrowhead Pharmaceuticals Inc and collaborate with the company to develop gene-silencing therapies for heart disease. 
Tags companyNews
From Reuters: Company News
< Previous 1 2
...
21 22 23 24 25 26 27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.